Skip Navigation



Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
Disease Category: Diabetes Mellitus, Type 2
Location: United States, FL

Clinical Trial Details


Research Study Summary

Overweight with Type II Diabetes?


This is a Phase II, randomized, double-blind placebo controlled study to evaluate the safety, efficacy and tolerability of an investigational medication administered in patients that are naive of diabetic medications, metformin only or metformin/sulfonylurea treatment. The study consists of 30 weeks with 11 office visits. You may be compensated for each completed office visit upon completion of the study.

Patient Inclusion Criteria:

  • Male/female 18 to 70
  • BMI must be >27.0-<45.0
  • Diagnosed with type II diabetes
  • HbA1c must be between 7.0% and 10%
  • Taking metformin (1500 mg daily) or alone or in combo with sulfonylurea
  • Cannot have any changes in dose for at least 2 months
  • Males/females must agree to use proper form of birth control

Patient Exclusion Criteria:

  • History or presence of type I diabetes or pancreatitis, acute ketoacidosis, lactic acidosis, hyperosmolar coma within the past 6 months
  • History of MI, unstable angina, class III/IV heart failure, PTCA, CABG, CVA, TIA within the past 6 months. Or history of severe peripheral vascular disease, or uncontrolled HTN
  • History of CA, BCC or SCC or carcinoma in situ of the cervix
  • History or presence of anorexia nervosa, bulimia nervosa, or binge eating disorder
  • History of acute or chronic gastrointestinal condition considered Clinically relevant (inflammatory bowel disease, IBS, or celiac sprue
  • Any unstable medical conditions

To Learn more



Both Male and Female


18 to 70 Years

Overall Status



30 Weeks

Facility Type



Lisa Dunham, Recruiting
Renstar Medical Research
104 SE 1st Ave Suite B
Ocala, FL 34471
Phone: 352-629-5800 ext 105
Fax: 352-629-7794

View Map

Research Center Information: Renstar Medical Research

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Zip/Postal Code:
Please leave this field empty.

CW ID: 156857

Date Last Changed: July 24, 2013

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.